Search - tctmd.com

Displaying 221 - 240 of 251

Sort: Relevancy | Date

News Industry News

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

October 18, 2012

News Industry News

Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension

October 03, 2012

News Industry News

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

October 01, 2012

News Daily News

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

September 13, 2012

News Daily News

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

September 13, 2012

News Industry News

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

September 12, 2012

News Daily News

Renal Stenting Shows Potential for Marked BP Lowering in Uncontrolled Hypertension

L.A. McKeown

September 10, 2012

News Daily News

Renal Denervation Reduces A-fib Recurrences in Small Study

Jason Kahn

September 07, 2012

News Daily News

La Denervación Renal Reduce las Recurrencias de la FA en un Pequeño Estudio

Jason Kahn

September 07, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

August 29, 2012

News Industry News

Medtronic Launches Resolute Integrity Coronary Stent System in Japan

August 28, 2012

News Daily News

Renal Denervation Part 2: How Far, How Fast for Promising New Therapy?

June 12, 2012

News Daily News

Renal Denervation: Treatment for Hypertension Captures Interventional Spotlight

June 05, 2012

News Industry News

Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure

May 16, 2012

News Industry News

Trial of Medtronic Symplicity™ Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment

April 27, 2012

News Industry News

ReCor Medical discloses new data from clinical study of its PARADISE™ ultrasound transcatheter renal denervation system for treating resistant hypertension

April 09, 2012

News Conference News ACC 2012

Symplicity Works: Renal Denervation Reduces Resistant Hypertension

Yael L. Maxwell

March 27, 2012

News Daily News

Experts Give Their Picks for Most Important Developments of 2011

Jason Kahn

March 08, 2012

News Daily News

Renal Denervation Bonus: Improving LV Function

March 05, 2012

Advertisement

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

Renal Stenting Shows Potential for Marked BP Lowering in Uncontrolled Hypertension

Renal Denervation Reduces A-fib Recurrences in Small Study

La Denervación Renal Reduce las Recurrencias de la FA en un Pequeño Estudio

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

Medtronic Launches Resolute Integrity Coronary Stent System in Japan

Renal Denervation Part 2: How Far, How Fast for Promising New Therapy?

Renal Denervation: Treatment for Hypertension Captures Interventional Spotlight

Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure

Trial of Medtronic Symplicity™ Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment

ReCor Medical discloses new data from clinical study of its PARADISE™ ultrasound transcatheter renal denervation system for treating resistant hypertension

Symplicity Works: Renal Denervation Reduces Resistant Hypertension

Experts Give Their Picks for Most Important Developments of 2011

Renal Denervation Bonus: Improving LV Function

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content